Laboratory research material only. Not for human or animal consumption.
Home/Shop/Klow 80mg
Klow 80mg research peptide vial · Polaris Research

Skin & Cosmetic · 80mg

Klow 80mg

$199
Low stock, selling fast
1
Free Express Delivery, No Minimum
Quality Certificate Included
Card, PayPal or PayID
Sealed Under Argon
Reserved for 24h Once Ordered

Klow (the KLOW peptide blend) is an expanded recovery-and-skin combination of BPC-157, TB-500, GHK-Cu, and KPV in a single 80mg vial. It takes the Glow trio and adds KPV, the C-terminal tripeptide of alpha-MSH studied for melanocortin and inflammation-pathway signalling, so one vial covers tissue signalling, collagen, and inflammation-pathway research together.The logic of a four-part blend is the same as any pairing: each compound should be studied for a different side of the goal, not pull redundantly on one pathway. BPC-157 and TB-500 cover tissue and angiogenesis signalling, GHK-Cu covers collagen and matrix remodelling, and KPV adds the melanocortin fragment studied for inflammation pathways. Klow is investigated as a complementary combination rather than an accumulation of more, and our Art of Pairing guide covers the restraint that makes combinations worth studying.Researchers wanting the three-part version can use the Glow 70mg blend, and those studying the components individually can use the single-compound GHK-Cu 50mg, BPC-157 10mg, and KPV 10mg vials. Klow is the fullest skin-and-repair reference in the range.Every 80mg vial ships lyophilised with an independently verified batch certificate at a guaranteed floor of ≥98% purity, verifiable on the batch verification page using the batch number on the label. Reconstitute with bacteriostatic water: add it slowly down the inside wall of the vial, swirl to dissolve, and never shake. Store the unopened vial at 2 to 8°C; refrigerate once reconstituted and do not refreeze.Buying the Klow blend in Australia is domestic: free Australia Post Express shipping to all states and territories, no minimum spend, dispatch from within Australia, and tracking on every parcel. Checkout accepts card, PayPal, or PayID, each vial is sealed under argon, and a 24-hour reservation holds your stock from order. Supplied strictly as a research material for lawful laboratory and in-vitro use, not for human or veterinary consumption.

Formal Name
Klow recovery blend
Purity
99.2% · batch-tested
Description
Expanded recovery and skin blend combining BPC-157, TB-500, GHK-Cu and KPV for matrix repair and inflammation-pathway research.
Research Focus
Cosmetic, recovery, collagen, tissue-remodelling and inflammation-pathway research.
Suggested Use
Reference plan: 4 mg total-blend aliquots once daily in a 12-week research block, followed by a 4-week break.
Doses per Vial
20 x 4 mg total-blend aliquots.
Concentration
4 mg total peptide blend per reference aliquot from an 80 mg vial.
Notes
Blend mass is total peptide mass; use KPV-containing blends where inflammation-pathway research is relevant.

Prepared with care, sealed under argon, and stored at 2–8°C until dispatch. Reconstitute with Bacteriostatic Water before use. Full preparation and storage guidance included with your order.

Independent Research
Evidence Overview on reptides.co

Independent third-party research on reptides.co — not affiliated with Polaris Research. Research reference only, not medical advice.

Pairs Well With

Complete your order

Related Reading

From the library

Also Searched As·Klow is also searched as KLOW peptide, Klow blend, BPC-157 TB-500 GHK-Cu KPV blend, Klow peptide blend.

Research File

What has been published on Klow

Accelerating

klow appears in 1,575 indexed publications going back to 1982, including 93 in the past twelve months. 19 registered trials appear on ClinicalTrials.gov.

1,575
Indexed publications
93
Past 12 months
19
Registered trials
Monthly readers
20152026

Publications per year. The final bar is the current year, still in progress.

Indexed publications per year
20151
20161
20172
20181
20192
20201
20211
20220
20230
20243
20251
20263
Read the full Klow research fileCounts from Europe PMC and ClinicalTrials.gov, refreshed weekly. Reported as a record of what exists, not as evidence of any effect.